Evidence map›Paper›PMID 36198631›Full record

ArticleAnnals of dermatology2022

The Clinical Manifestation of p.Asp50Asn Heterozygous Mutation of

Yanjiang Xu, Minhua Wang, Ling Huang, Jie Hu

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Annals of dermatology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Yanjiang XuSchool of Clinical Medicine, Dali University, Dali, Yunnan, China.ORCID https://orcid.org/0000-0002-2602-2924
Minhua WangDepartment of Dermatology, The First Affiliated Hospital of Dali University, Dali, Yunnan, China. wmh368@126.com.ORCID https://orcid.org/0000-0001-7604-6142
Ling HuangDepartment of Dermatology, The First Affiliated Hospital of Dali University, Dali, Yunnan, China.ORCID https://orcid.org/0000-0002-6094-173X
Jie HuSchool of Clinical Medicine, Dali University, Dali, Yunnan, China.ORCID https://orcid.org/0000-0003-0357-925X
Dali University · CN

Funding

Clinical Medical Center for Immunological Skin Diseases
6 · The paper itself

Abstract

Keratitis-ichthyosis-deafness (KID) syndrome has genetic heterogeneity, and the clinical manifestations of some patients may overlap with Clouston syndrome. A 34-year-old female patient came to our department with a complain of "sparse hair, rough skin, photophobia and deafness for more than 30 years." We found that the proband and two other family members (57-year-old mother and 4-year-old daughter) had similar clinical manifestations: systemic hair loss, generalized skin hyperkeratosis, especially in the metacarpophalangeal area. Subungual hyperkeratosis, finger/toenail dystrophy, as well as photophobia and epiphora. According to the investigation, one of the family members also had similar clinical manifestations (grandfather of the proband) and he's died. The other three members of the family had no hearing impairment, and all patients had typical nail dystrophy, hair loss and palmoplantar hyperkeratosis, similar like as seen in Clouston syndrome, so we suspected to diagnose the case as Clouston syndrome. However, after genetic testing, it was found that the proband, his mother and daughter all had p.Asp50Asn heterozygous mutations in the

Indexed as

Clouston syndromeConnexin 26

Identifiers

PMID36198631
PMCPMC9561302
OpenAlexW4296757576

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.